Eupraxia Pharmaceuticals Inc. Common Stock (EPRX)
Stock · NASDAQ · Health Care
$6.68as of 8/28/2026
Price chart
Open in TradingViewAbout EPRX
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI…
- Sector
- Health Care
- Industry
- Pharmaceuticals and Biotechnology
- Employees
- 49
Fundamentals
- 1-day range
- $6.67$7.45
- Market cap
- $425.28M
- P/E (trailing)
- —
- P/E (forward)
- -6.41
- EPS (trailing)
- $-0.96
- Dividend yield
- —
- Beta
- 1.25
- Avg. volume
- 374.8K
52-week range
$7.01$12.86
Next earnings: November 3, 2026 · EPS estimate $-0.26
Forecasts
10 analyst ratings
Buy 91%
Hold 9%
Sell 0%
1-year price forecast
High
$25
+274.5%
Median
$15.75
+136.0%
Low
$11
+64.8%
Eupraxia Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- EPRXEupraxia Pharmaceuticals Inc. Common Stock$6.67▼ 9.44%Market cap $425.28MP/E —$7.01$12.86
- OCGNOcugen Inc. Common Stock$1.32▼ 3.65%Market cap $423.89MP/E —$1$2.73
- BNTCBenitec Biopharma Inc. Common Stock$12.51▼ 1.30%Market cap $417.41MP/E —$9.85$16.76
- KMDAKamada Ltd. Ordinary Shares$8.29▲ 0.36%Market cap $417.07MP/E 20.65$6.5$9.35
- STROSutro Biopharma Inc. Common Stock$20.42▼ 4.18%Market cap $415.92MP/E —$7.15$43.85
- PRTAProthena Corporation plc Ordinary Shares$9.35▲ 2.86%Market cap $436.10MP/E —$7.73$11.8
- LRMRLarimar Therapeutics Inc. Common Stock$4▼ 1.23%Market cap $413.45MP/E —$2.72$6.42
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EPRX Eupraxia Pharmaceuticals Inc. Common Stock | $425.28M | — | $6.67 | ▼ 9.44% | $7.01$12.86 |
| OCGN Ocugen Inc. Common Stock | $423.89M | — | $1.32 | ▼ 3.65% | $1$2.73 |
| BNTC Benitec Biopharma Inc. Common Stock | $417.41M | — | $12.51 | ▼ 1.30% | $9.85$16.76 |
| KMDA Kamada Ltd. Ordinary Shares | $417.07M | 20.65 | $8.29 | ▲ 0.36% | $6.5$9.35 |
| STRO Sutro Biopharma Inc. Common Stock | $415.92M | — | $20.42 | ▼ 4.18% | $7.15$43.85 |
| PRTA Prothena Corporation plc Ordinary Shares | $436.10M | — | $9.35 | ▲ 2.86% | $7.73$11.8 |
| LRMR Larimar Therapeutics Inc. Common Stock | $413.45M | — | $4 | ▼ 1.23% | $2.72$6.42 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis PatientsYahoo · 8/13/2026
- Eupraxia Pharmaceuticals Q2 EPS $(0.23), Inlinebenzinga · 8/11/2026
- Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial ResultsYahoo · 8/11/2026
- Eupraxia Pharmaceuticals Q2 EPS $(0.23), InlineBenzinga · 8/11/2026
- Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?Yahoo · 8/10/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 21.98M
- Total value held
- $128.92M
- Institutional holders
- 53
Top holders this quarter
- Unknown3.67M
- Unknown1.59M
- Unknown1.35M
- Unknown1.35M
- Unknown1.34M
- Unknown1.21M
- Unknown1.20M
- Unknown967.6K
- Unknown762.6K
- Unknown700.0K
See the full, filterable feed with live charts on the MarketWall dashboard.